Ind. Panel: Contaminated Drug Claims Against Clinics Constitute Medical Malpractice

(November 10, 2016, 2:57 PM EST) -- INDIANAPOLIS — Plaintiffs’ claims against medical providers that administered a contaminated steroid that caused fungal meningitis are subject to the provisions of the Indiana Medical Malpractice Act (MMA), the state Court of Appeals ruled Nov. 7, rejecting the state compensation fund administrator’s argument that the claims sound in general negligence (Stephen W. Robertson, Commissioner, Indiana Department of Insurance, as Administrator of the Indiana Patient’s Compensation Fund v. Anonymous Clinic, et al., and Stephen W. Robertson, Commissioner, Indiana Department of Insurance, as Administrator of the Indiana Patient’s Compensation Fund v. Orthopedic and Sports Medicine Center of Northern Indiana, et al., No. 71A03-1512-CT-2199, Ind. App.; 2016 Ind. App. LEXIS 402)....

Attached Documents

Related Sections